By Padmanabhan Ananthan Aug 26 (Reuters) – The U.S. FDA has approved Revolution Medicines' groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Blake Lively's request for legal fees partially granted following Justin Baldoni settlement
Los Angeles [US], August 26 (ANI): A judge on Wednesday awarded Blake Lively approximately USD…
Wawrinka handed U.S. Open wildcard after fan outcry
VIDEO SHOWS: ARCHIVE PHOTO OF STAN WAWRINKA IN ACTION AT THE U.S. OPEN / ARCHIVE…
BANK OF MEXICO FORECASTS 2026 GDP GROWTH AT 1.5% VERUSUS 1.1% IN PREVIOUS QUARTERLY REPORT
BANK OF MEXICO FORECASTS 2026 GDP GROWTH AT 1.5% VERUSUS 1.1% IN PREVIOUS QUARTERLY REPORT…
